Picture of Biocartis NV logo

BCART — Biocartis NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareBalancedMicro Cap

Brief: Biocartis Gets EUR 1.2 Mln Grant For Idylla GeneFusion Assay

Sept 30 (Reuters) - Biocartis Group NV  BCART.BR :
    * REG-PRESS NEWS BIOCARTIS GROUP NV: BIOCARTIS RECEIVES EUR
1.2
MILLION GRANT FOR DEVELOPMENT OF HIGHLY INNOVATIVE IDYLLA™
GENEFUSION ASSAY
    * EXPECTS TO LAUNCH ITS IDYLLA GENEFUSION ASSAY AS A
RESEARCH USE
ONLY (RUO) ASSAY IN Q1 2021
    * VALIDATION AND RELEASE OF AN IVD VERSION FOR USE IN NSCLC
IS
ALSO ANTICIPATED.

Source text for Eikon:  ID:nGNE3mLPFy 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biocartis NV

See all news